Reed Tech
@ReedTechLifeSci
Followers
433
Following
651
Media
2K
Statuses
4K
Regulatory compliance and product data mgt solutions and services for medical device and pharmaceutical labelers. #medicaldevices #pharma #udi #regulatory
Horsham, PA
Joined January 2014
Last chance to register for tomorrow's LexisNexis Reed Tech webinar on Health Canada! Don't miss out on this opportunity to equip your organization with the knowledge and tools needed for success! 📅 Thursday, March 6th | 2 PM ET 👉 Register now: https://t.co/tKnMSzYGqD
1
1
2
Did you know? LexisNexis Reed Tech is responsible for over 50% of voluntary XML PM submissions made to Health Canada. Who better to learn from than the experts? Join us Thursday, March 6th for a free, educational webinar. https://t.co/yw4nk92ZnM
go.reedtech.com
Join us for a comprehensive webinar on the newly announced Health Canada XML Product Monograph (PM), a pivotal development for pharmaceutical companies operating in Canada.
0
0
1
Sneak Peek: Here's some of what you'll learn in our upcoming webinar | Mastering Health Canada XML PM Monographs: Insights and Strategies from LexisNexis Reed Tech Thursday, 3/6 | 2 PM ET Register now: https://t.co/sublZHDmkA
#HealthCanada #XMLPM #Regulatory
0
0
1
Did you know that missing FDA filing deadlines can lead to your drug products being marked as inactive? Learn more about the implications of inactive status and how to resolve it in our latest blog post. https://t.co/p4i7TfHd4V
#Pharmaceuticals #FDACompliance #RegulatoryUpdates
reedtech.com
The Food and Drug Administration (FDA) requires drug manufacturers to keep their listings updated each year.
0
1
1
Considering registering for the Reed Tech webinar on Health Canada? Here is why you should. This is a crucial regulation for pharma companies selling in Canada. Understanding these changes is vital to maintaining compliance and market access. Register now: https://t.co/hfKC9sqKFE
0
0
2
Did you know? LexisNexis Reed Tech is responsible for 50% + of voluntary XML PM submissions made to Health Canada. Who better to learn from than the experts? Join us March 6th for a webinar designed to help you prepare for upcoming required submissions. https://t.co/38vITBFsGt
go.reedtech.com
Join us for a comprehensive webinar on the newly announced Health Canada XML Product Monograph (PM), a pivotal development for pharmaceutical companies operating in Canada.
0
1
1
WEBINAR ANNOUNCEMENT | Mastering Health Canada XML PM Mandates: Insights and Strategies from LexisNexis Reed Tech Register now for this free, educational webinar: https://t.co/dfni56EEY5
0
0
0
It's the last day of #RSIDM2025! Come visit us at booth 303. Our experts are ready and waiting for your questions.
0
0
0
Join us at DIA RSIDM 2025 in Bethesda, MD, booth 303, to explore our eCTD and Compliance as a Service (CaaS) solutions for Medical Device and Pharma. Our team of experts is here to answer any questions you may have about how our services can support your compliance needs.
0
0
0
The FDA has updated GMDN Codes compliance in the GUDID to enhance standardization and device classification. Read this blog for more information. https://t.co/Nhk8CM4GYt
0
0
0
Breaking News: FDA to Revoke Authorization for Red No. 3 in Food and Drugs! Read the LexisNexis Reed Tech blog post to learn more:
reedtech.com
FDA is taking a decisive step to revoke the authorization for the use of Food, Drug & Cosmetic Red No. 3 in food and ingested drugs.
0
0
0
Exciting Update: The FDA has made enhancements to the GUDID guidance. Stay informed and ensure your compliance by reviewing the updated guidance today! Contact Reed Tech to learn more or get expert help with your UDI submissions - meddevice@reedtech.com.
fda.gov
Provides information necessary for submitting data to the Global Unique Device Identification Database (GUDID). Primarily intended for device labelers.
0
0
0
Last week, the European Commission released a Q&A on practical aspects related to implementing the gradual roll-out of EUDAMED. In this new blog, we will cover highlights from the document and recommendations for the next steps https://t.co/GggTc30ViU
0
0
0
LexisNexis Reed Tech is expanding our Life Sciences Team! We are accepting applications for the following positions. Apply today to join our team of industry experts! Senior Account Executive: https://t.co/Tj1lezU1So Strategic Account Sales Executive: https://t.co/oU4CV7EB02
0
0
0
Health Canada is introducing the mandatory use of XML PM in phases, with the first phase taking effect on July 18, 2025. To learn more, read our post below. To get started with your submissions NOW, contact us at pharma@reedtech.com or +1(215) 557-3010. https://t.co/npt1VeNtmz
reedtech.com
Health Canada is introducing the mandatory use of the extensible markup language product monograph (XML PM) in phases, with the first phase taking effect on July 18, 2025. This initial phase will...
0
0
0
Regulatory compliance is key in today's global business landscape. Unique regulations across countries make managing regulatory activities challenging. Partnering with a single, experienced UDI vendor can be highly beneficial. Read our blog to learn more: https://t.co/UhbPeQ9nrY
0
0
0
On October 15, 2024, Reed Tech and 1WorldSync hosted a webinar led by Gary Saner and Scott Brown, focusing on how their alliance aids companies in UDI management and GDSN use for compliance and partner requirements. Learn more here: https://t.co/96XZ3dyUtp
0
0
1
Breaking news: FDA has approved a modification to the Opioid Analgesic Risk Evaluation and Mitigation Strategy (OA REMS). Learn more in our full blog post: https://t.co/ffO2SSQ3GX
reedtech.com
The FDA approved OA REMS changes, providing free pre-paid drug mail-back envelopes from outpatient pharmacies.
0
0
0
Join LexisNexis Reed Tech for a free, educational webinar examining nuances of the CARES Act. Plus, Gary Saner will fill you in on what to do if you have already missed the first deadline! Register now: https://t.co/0yenJbJka7
0
0
0